Streetbeat News

Stock Prices

BMY

TEVA

Bristol Myers Squibb Co (BMY) is facing a lawsuit from Blue Cross Blue Shield of Louisiana, accusing the company of using deceptive patents and illicit strategies to maintain its dominance in the blood cancer drug market with Pomalyst. The lawsuit alleges that BMY violated U.S. antitrust laws, leading to overpayment for Pomalyst. The lawsuit seeks damages equal to three times the alleged overcharge. In 2022, Pomalyst generated nearly $3.5 billion in revenue out of Bristol Myers' total of $46.16 billion.

Portfolio Pulse from Vandana Singh

September 07, 2023 | 2:03 pm

FMC

FMC Corp's shares are trading lower following a short report by Blue Orca Capital. The report cites FMC's non-disclosure of recent legal defeats that have allowed competitors to sell generics at up to 80% below the price of FMC's flagship insecticide.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 2:02 pm

AMEH

BASE

CVGW

DBI

GIII

NRIX

PATH

WLY

WRK

Despite a mostly lower trading day, several stocks recorded gains. Designer Brands, G-III Apparel Group, and Calavo Growers reported upbeat Q2 and Q3 results respectively, leading to significant stock price increases. Nurix Therapeutics rose after a deal with Seagen, while Couchbase gained following Q2 results. WestRock Company is discussing a potential combination with Smurfit Kappa Group, and UiPath reported better-than-expected Q2 results. Apollo Medical Holdings and John Wiley & Sons also saw increases following strong quarterly results.

Portfolio Pulse from Lisa Levin

September 07, 2023 | 2:01 pm

META

A significant bearish stance has been taken on Meta Platforms (NASDAQ:META) by a large investor, as indicated by a large position in options. The sentiment among these big-money traders is split, with 41% bullish and 58% bearish. Whales have been targeting a price range from $295.0 to $315.0 for Meta Platforms over the last 3 months. RBC Capital and Wedbush have downgraded their actions to Outperform with price targets of $400 and $350 respectively, while Loop Capital maintains a Buy rating with a price target of $375.

Portfolio Pulse from Benzinga Insights

September 07, 2023 | 2:01 pm

DCGO

DocGo (NASDAQ:DCGO) has received 9 bullish analyst ratings in the last quarter, with no bearish or indifferent ratings. The average 12-month price target for the stock, according to these analysts, is $13.56, with a high of $15.00 and a low of $12.00. This average price target has increased by 13.0% over the past month.

Portfolio Pulse from Benzinga Insights

September 07, 2023 | 2:00 pm

WULF

In the last quarter, TeraWulf (NASDAQ:WULF) received 8 bullish ratings from analysts, with an average 12-month price target of $4.03, up by 0.75% from the previous average price target of $4.00. No bearish or indifferent ratings were observed.

Portfolio Pulse from Benzinga Insights

September 07, 2023 | 2:00 pm

RENT

Rent the Runway (NASDAQ:RENT) is set to release its quarterly earnings report on September 8, 2023. Analysts estimate an earnings per share (EPS) of $-0.43. The company's past performance shows a pattern of share price drops following earnings reports, with shares currently trading at $1.36 and down 71.09% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

September 07, 2023 | 2:00 pm

TPH

Analysts have provided somewhat bullish ratings for Tri Pointe Homes (NYSE:TPH) in the last quarter, with an average price target of $35.5, implying an upside from the current price of $29.895. The average price target has increased by 20.34% over the past month.

Portfolio Pulse from Benzinga Insights

September 07, 2023 | 2:00 pm

KR

Kroger (NYSE:KR) is set to release its latest quarterly earnings report on September 8, 2023. Analysts estimate an earnings per share (EPS) of $0.91. The company's past performance shows a trend of beating EPS estimates. However, the stock has seen a 12.32% decrease over the last 52-week period.

Portfolio Pulse from Benzinga Insights

September 07, 2023 | 2:00 pm

VRNT

Verint Systems Inc reported worse-than-expected earnings, leading to a drop in its share price. Several analysts have also cut their price targets on the stock.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 1:57 pm